{"id":50126,"date":"2022-12-13T10:04:44","date_gmt":"2022-12-13T09:04:44","guid":{"rendered":"https:\/\/www.aiom.it\/?p=50126"},"modified":"2022-12-14T10:05:34","modified_gmt":"2022-12-14T09:05:34","slug":"overall-survival-with-first-line-atezolizumab-in-combination-with-vemurafenib-and-cobimetinib-in-brafv600-mutation-positive-advanced-melanoma-imspire150-second-interim-analysis-of-a-multicentre-ra","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/overall-survival-with-first-line-atezolizumab-in-combination-with-vemurafenib-and-cobimetinib-in-brafv600-mutation-positive-advanced-melanoma-imspire150-second-interim-analysis-of-a-multicentre-ra\/","title":{"rendered":"Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study"},"content":{"rendered":"<p><em>Prof Paolo A Ascierto, Daniil Stroyakovskiy, Prof Helen Gogas,Prof Caroline Robert, Prof Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Prof Jacob Schachter,Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Prof Grant A McArthur, Prof Ralf Gutzmer <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-49269\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2022\/10\/Lancet-Oncology_Oct22-223x300.jpg\" alt=\"\" width=\"223\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2022\/10\/Lancet-Oncology_Oct22-223x300.jpg 223w, https:\/\/www.aiom.it\/wp-content\/uploads\/2022\/10\/Lancet-Oncology_Oct22.jpg 571w\" sizes=\"auto, (max-width: 223px) 100vw, 223px\" \/><\/em><\/p>\n<p><em>The Lancet Oncology<\/em>, Novembrer 29, 2022<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(22)00687-8\/fulltext\">Abstract link<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prof Paolo A Ascierto, Daniil Stroyakovskiy, Prof Helen Gogas,Prof Caroline Robert, Prof Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Prof Jacob Schachter,Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Prof Grant A McArthur, Prof Ralf Gutzmer The Lancet Oncology, Novembrer 29, 2022 Abstract link<\/p>\n","protected":false},"author":11,"featured_media":49273,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-50126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/50126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=50126"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/50126\/revisions"}],"predecessor-version":[{"id":50128,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/50126\/revisions\/50128"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/49273"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=50126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=50126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=50126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}